CORC

浏览/检索结果: 共1条,第1-1条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) vs gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFRM plus ) advanced adenocarcinoma of the lung 会议论文
作者:  Wu, Yi-Long;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace